These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 1629304

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
    Goldwirt L, Lemaitre F, Zahr N, Farinotti R, Fernandez C.
    J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
    [Abstract] [Full Text] [Related]

  • 25. Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies.
    Poujol S, Pinguet F, Malosse F, Astre C, Ychou M, Culine S, Bressolle F.
    Clin Chem; 2003 Nov; 49(11):1900-8. PubMed ID: 14578322
    [Abstract] [Full Text] [Related]

  • 26. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T, Awasthi A, Jaggi M, Khar RK, Talegaonkar S.
    Talanta; 2008 Sep 15; 76(5):1015-21. PubMed ID: 18761148
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic characteristics of the novel anticancer agent CPT-11 and its active metabolite in plasma and lung lymph fluid following intravenous administration to sheep.
    Koizumi T, Kubo K, Hanaoka M, Miyahara T, Kaneki T, Yamamoto H, Ge RL, Fujimoto K, Kobayashi T, Sekiguchi M.
    Arzneimittelforschung; 1998 Nov 15; 48(11):1097-100. PubMed ID: 9850432
    [Abstract] [Full Text] [Related]

  • 30. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C, Chansriwong P, Sirachainan E, Reungwetwattana T, Puangpetch A, Prommas S, Sirilerttrakul S, Rerkarmnuaychoke B, Wongwaisayawan S, Sukasem C.
    J Clin Lab Anal; 2018 Jan 15; 32(1):. PubMed ID: 28393405
    [Abstract] [Full Text] [Related]

  • 31. High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma.
    Schoemaker NE, Frigerio E, Fraier D, Schellens JH, Rosing H, Jansen S, Beijnen JH.
    J Chromatogr B Biomed Sci Appl; 2001 Nov 05; 763(1-2):173-83. PubMed ID: 11710576
    [Abstract] [Full Text] [Related]

  • 32. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E, Posocco B, Mazzega E, Toffoli G.
    PLoS One; 2015 Nov 05; 10(2):e0118194. PubMed ID: 25689738
    [Abstract] [Full Text] [Related]

  • 33. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
    Bissery MC, Vrignaud P, Lavelle F, Chabot GG.
    Anticancer Drugs; 1996 Jun 05; 7(4):437-60. PubMed ID: 8826613
    [Abstract] [Full Text] [Related]

  • 34. Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: application to cellular metabolism and accumulation studies.
    Hu ZP, Yang XX, Chen X, Chan E, Duan W, Zhou SF.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May 01; 850(1-2):575-80. PubMed ID: 17270505
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38.
    Sasaki Y, Mizuno S, Fujii H, Ohtsu T, Wakita H, Igarashi T, Itoh K, Sekine I, Miyata Y, Saijo N.
    Jpn J Cancer Res; 1995 Jan 01; 86(1):117-23. PubMed ID: 7737903
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
    Rivory LP, Haaz MC, Canal P, Lokiec F, Armand JP, Robert J.
    Clin Cancer Res; 1997 Aug 01; 3(8):1261-6. PubMed ID: 9815808
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.